China approves first commercial brain implant to restore hand movement in paralysis patients

China has granted the first commercial authorization for a brain-computer interface device developed by Neuracle Medical Technology to help paralysis patients regain hand movement. The system detects intended movements from brain signals and drives a robotic glove via software, enabling grasping objects; eligibility is limited to adults 18-60 with paralysis for over a year and stable for at least six months. This milestone highlights China’s push into BCI tech as a national strategic priority, while rival efforts like Neuralink are targeting high-volume production in 2026.